TTD Drug ID: DAP000614

Drug Information
Name	Sildenafil
Synonyms	KBio2_002035; KBioGR_001052; C22H30N6O4S; 5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one; 5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one; Ambap139755-83-2; 171599-83-0 (citrate); I06-0023; VIA; 2h42; SMR000752512; Spectrum2_001648; Piperazine, 1-((3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methyl-; Aphrodil (TN); 5-[2-Ethoxy-5-(4-methyl-piperazine-1-sulfonyl)-phenyl]-1-methyl-3-propyl-1,6-dihydro-pyrazolo[4,3-d]pyrimidin-7-one (Sildenafil or Viagra); Sildenafil (INN); HMS2089M12; KBio1_001838; UK-92,480-10; LS-111655; BAS 04213629; Sildenafil [INN:BAN]; DB00203; D08514; 1udt; AC-938; BIDD:GT0352; HMS1922B19; sildenafil; HMS2093O17; NCGC00095099-01; 5-(2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one; SpecPlus_000798; KBioSS_002035; Aphrodil; Spectrum5_001508; 5-{2-(ethyloxy)-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one; NCGC00095099-02; MolPort-001-995-394; UK-92480; 139755-83-2; 1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine; HMS1684K08; MLS001240224; CHEBI:9139; KBio2_004603; HSDB 7305; 1xos; DivK1c_006894; MolPort-002-885-861; Spectrum_001555; UNII-3M7OB98Y7H; MLS001304737; KBio2_007171; Spectrum3_001892; BSPBio_003424; SPECTRUM1504099; Jsp002373; 1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate; AC1L1JUI; CID5212; SPBio_001775; BRD-K79759585-001-02-1; NCGC00159496-02; Spectrum4_000586; KBio3_002927; 5-[2-Ethoxy-5-(4-methyl-piperazine-1-sulfonyl)-phenyl]-1-methyl-3-propyl-1,6-dihydro-pyrazolo[4,3-d]pyrimidin-7-one(Sildenafil); CHEMBL192; C07259
Trade Name	Viagra; Revatio
Company	Pfizer Pharmaceuticals
Indication	Erectile dysfunction			Approved    [1]
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
Therapeutic Class	Anti-Impotence Agents
CAS Number	CAS 139755-83-2
Formular	C22H30N6O4S
PubChem Compound ID	CID 5212.
PubChem Substance ID	SID 9468.
SuperDrug ATC ID	G04BE03;
SuperDrug CAS ID	139755832;
Target	CGMP-specific 3',5'-cyclic phosphodiesterase			Inhibitor	[2][3][4][5]
Ref 1	Pharmacologic therapeutics for cardiac reperfusion injury. Expert Opin Emerg Drugs. 2007 Sep;12(3):367-88. To Reference
Ref 2	cGMP-hydrolytic activity and its inhibition by sildenafil in normal and failing human and mouse myocardium. J Pharmacol Exp Ther. 2009 Jun 22. [Epub ahead of print] To Reference
Ref 3	Efficacy and safety of sildenafil citrate (Viagra) in men with erectile dysfunction and spinal cord injury: a review. Urology. 2002 Sep;60(2 Suppl 2):49-57. To Reference
Ref 4	Nat Rev Drug Discov. 2003 Jan;2(1):38-51.Knockouts model the 100 best-selling drugs--will they model the next 100? To Reference
Ref 5	Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int J Impot Res. 2002 Dec;14(6):466-71. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.